发明名称 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
摘要 An 8-azaprostaglandin represented by formula (I) (wherein all symbols have the same meanings as described in the specification), a pharmaceutically acceptable salt thereof or a cyclodextrin clathrate thereof. Since the compound represented by formula (I) binds to EP2 subtype among PGE receptor strongly, it is useful for preventive and/or treatment for immune diseases, allergic diseases, neuronal cell death, dysmenorrhea, premature birth, abortion, baldness, retinal neuropathy such as glaucoma, erectile dysfunction, arthritis, pulmonary injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, hepatic injury, acute hepatitis, liver cirrhosis, shock, nephritis, renal failure, circulatory diseases, systemic inflammatory response syndrome, sepsis, hemophagocytosis syndrome, macrophage activation syndrome, still disease, Kawasaki Disease, burn, systemic granuloma, ulcerative colitis, Crohn disease, hypercytokinemia at dialysis, multiple organ failure, or bone diseases etc.
申请公布号 US7683094(B2) 申请公布日期 2010.03.23
申请号 US20080139260 申请日期 2008.06.13
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 TANI KOUSUKE;KOBAYASHI KAORU;MARUYAMA TORU;KAMBE TOHRU;OGAWA MIKIO;SHIROYA TSUTOMU
分类号 A61K31/40;C07D207/27;A61P1/00;A61P1/16;A61P7/00;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P11/08;A61P13/12;A61P15/06;A61P15/10;A61P19/02;A61P19/08;A61P19/10;A61P25/00;A61P27/02;A61P29/00;A61P35/00;A61P37/02;A61P43/00;C07D207/00;C07D207/26;C07D263/24;C07D405/06;C07D405/12;C07D409/06;C07D409/12;C07D413/06;C07D413/12;C07D417/06;C07D417/12 主分类号 A61K31/40
代理机构 代理人
主权项
地址